Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review

BACKGROUND: Programmed cell death-1 (PD-1) inhibitor has been indicated for many types of malignancies. However, these inhibitors also cause immune-related adverse events. Hepatobiliary disorder is a phenotype of immune-related adverse event affecting 0%–4.5% of patients treated with PD-1 inhibitors...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Onoyama, Takumi, Takeda, Yohei, Yamashita, Taro, Hamamoto, Wataru, Sakamoto, Yuri, Koda, Hiroki, Kawata, Soichiro, Matsumoto, Kazuya, Isomoto, Hajime
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2020
Assuntos:
Systematic Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6969883/
https://ncbi.nlm.nih.gov/pubmed/31988594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i3.353
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados